Tower Research Capital (TRC)’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$648 Sell
810
-4,108
-84% -$3.29K ﹤0.01% 4971
2025
Q1
$4.51K Sell
4,918
-1,093
-18% -$1K ﹤0.01% 4246
2024
Q4
$5.71K Buy
6,011
+2,981
+98% +$2.83K ﹤0.01% 4254
2024
Q3
$3.85K Sell
3,030
-12,868
-81% -$16.3K ﹤0.01% 4756
2024
Q2
$20.7K Buy
15,898
+8,001
+101% +$10.4K ﹤0.01% 3748
2024
Q1
$12.1K Sell
7,897
-6,115
-44% -$9.36K ﹤0.01% 3513
2023
Q4
$16.4K Buy
14,012
+3,176
+29% +$3.72K ﹤0.01% 3781
2023
Q3
$9.43K Buy
+10,836
New +$9.43K ﹤0.01% 4218
2023
Q2
Sell
-64
Closed 6044
2023
Q1
$0 Buy
+64
New ﹤0.01% 5857
2022
Q4
Sell
-2,440
Closed -$2K 5938
2022
Q3
$2K Buy
2,440
+1,763
+260% +$1.45K ﹤0.01% 5533
2022
Q2
$1K Sell
677
-7,642
-92% -$11.3K ﹤0.01% 5751
2022
Q1
$19K Sell
8,319
-4,316
-34% -$9.86K ﹤0.01% 3569
2021
Q4
$35K Buy
12,635
+9,688
+329% +$26.8K ﹤0.01% 3074
2021
Q3
$18K Buy
+2,947
New +$18K ﹤0.01% 3811
2021
Q2
Sell
-16,672
Closed -$41K 5511
2021
Q1
$41K Buy
16,672
+11,944
+253% +$29.4K ﹤0.01% 3284
2020
Q4
$13K Sell
4,728
-7,744
-62% -$21.3K ﹤0.01% 4134
2020
Q3
$19K Buy
12,472
+11,352
+1,014% +$17.3K ﹤0.01% 3879
2020
Q2
$2K Buy
+1,120
New +$2K ﹤0.01% 4474
2019
Q3
Sell
-7,722
Closed -$8K 4128
2019
Q2
$8K Buy
7,722
+6,849
+785% +$7.1K ﹤0.01% 2676
2019
Q1
$1K Sell
873
-3,906
-82% -$4.47K ﹤0.01% 3540
2018
Q4
$5K Buy
4,779
+2,988
+167% +$3.13K ﹤0.01% 2885
2018
Q3
$11K Sell
1,791
-5,383
-75% -$33.1K ﹤0.01% 2685
2018
Q2
$77K Sell
7,174
-5,001
-41% -$53.7K ﹤0.01% 1597
2018
Q1
$130K Buy
+12,175
New +$130K 0.01% 1102
2017
Q4
Sell
-2,768
Closed -$24K 3582
2017
Q3
$24K Buy
+2,768
New +$24K ﹤0.01% 2608
2017
Q1
Sell
-2,690
Closed -$24K 3147
2016
Q4
$24K Sell
2,690
-6,631
-71% -$59.2K ﹤0.01% 1964
2016
Q3
$162K Buy
9,321
+8,821
+1,764% +$153K 0.02% 584
2016
Q2
$4K Buy
+500
New +$4K ﹤0.01% 3503